Hikma Pharmaceuticals · 3 hours ago
Intern, Legal
Berkeley Heights
Internship
Onsite
InternHikma Pharmaceuticals USA Inc. is a developer, manufacturer, and supplier of essential medicines. They are seeking a motivated and detail-oriented North American Legal Intern to contribute to various legal issues affecting the company's business through research, drafting documents, and collaboration with different teams.
Health CareMedicalPharmaceutical
No H1B
Responsibilities
Ability to lead on various tasks as required from time to time to support Hikma’s business and the North America Legal Department
Qualification
Required
Must be a law student in good standing at an ABA-accredited law school with excellent academic credentials
Students should have excellent academic credentials and communication skills
All candidates must be authorized to work in the U.S. both at the time of hire and for the duration of their internship
Professional communication and collaboration skills
Solid computer skills, with an emphasis on Microsoft Office (Excel/Word)
Ability to work independently while supporting a team-driven environment
Work with urgency to ensure that inquiries are efficiently managed
Must possess excellent written and verbal communication skill
Ability to manage multiple project activities under general supervision
Must be organized and detail/deadline oriented
Regular and predictable onsite attendance and punctuality
Must be legally authorized to work in the United States without restriction, no sponsorship offered at this time
Must be willing to submit to a background investigation, including verification of your past employment, criminal history, and educational background
Must be willing to take a drug test
Must be 18 years of age or older
Preferred
Experience in health/life sciences is preferred
Company
Hikma Pharmaceuticals
Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products
Founded in 1978
5001-10000 employees
Funding
Current Stage
Public CompanyTotal Funding
$250MKey Investors
International Finance Corporation
2025-07-15Post Ipo Debt· $250M
2005-11-04IPO
Leadership Team
Said Darwazah
Chief Executive Officer
Khalid Nabilsi
Chief Financial Officer
Recent News
2026-02-03
Pharma Letter
2026-01-22
BioWorld Financial Watch
2026-01-21
Company data provided by crunchbase